Evelo Biosciences (EVLO) Competitors $0.0005 0.00 (0.00%) As of 01/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends EVLO vs. SCPS, NAVB, CMRA, GNCAQ, GNCA, ARDS, STAB, AMPE, EFTR, and ONCSQShould you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Scopus BioPharma (SCPS), Navidea Biopharmaceuticals (NAVB), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), and OncoSec Medical (ONCSQ). These companies are all part of the "pharmaceutical products" industry. Evelo Biosciences vs. Scopus BioPharma Navidea Biopharmaceuticals Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma Ampio Pharmaceuticals eFFECTOR Therapeutics OncoSec Medical Scopus BioPharma (NASDAQ:SCPS) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation. Do insiders and institutionals hold more shares of SCPS or EVLO? 0.3% of Evelo Biosciences shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor SCPS or EVLO? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Evelo Biosciences'average media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Evelo Biosciences Neutral Which has higher valuation and earnings, SCPS or EVLO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/AEvelo BiosciencesN/AN/A-$114.53M-$13.290.00 Which has more volatility & risk, SCPS or EVLO? Scopus BioPharma has a beta of -0.21, suggesting that its share price is 121% less volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Is SCPS or EVLO more profitable? Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Evelo Biosciences N/A N/A N/A Does the MarketBeat Community favor SCPS or EVLO? Evelo Biosciences received 168 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 60.50% of users gave Evelo Biosciences an outperform vote. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesEvelo BiosciencesOutperform Votes17060.50% Underperform Votes11139.50% SummaryScopus BioPharma and Evelo Biosciences tied by winning 3 of the 6 factors compared between the two stocks. Ad StocksToTradeliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…Click here to discover the real reason Elon Musk became buddy-buddy with Trump. Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVLO vs. The Competition Export to ExcelMetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9,000.00$6.60B$5.24B$8.94BDividend YieldN/A2.91%5.30%4.03%P/E Ratio0.0010.4587.2317.09Price / SalesN/A198.971,115.43124.64Price / CashN/A57.1143.1337.81Price / Book0.005.075.124.99Net Income-$114.53M$153.18M$121.58M$226.97M7 Day PerformanceN/A1.63%2.36%0.78%1 Month PerformanceN/A-3.28%18.81%0.81%1 Year PerformanceN/A-0.56%27.00%14.53% Evelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120SCPSScopus BioPharmaN/A$0.00+50.0%N/A-99.3%$13,000.00N/A0.009Gap UpNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-99.8%$10,000.00$8,126.000.0010High Trading VolumeCMRAComera Life SciencesN/A$0.00flatN/A-99.7%$6,000.00$1.00M0.002High Trading VolumeGNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.64M0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.8%$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/AN/A$5,000.00$1.49M0.0020High Trading VolumeAMPEAmpio PharmaceuticalsN/A$0.00+420.0%N/A-95.2%$3,000.00N/A0.0020EFTReFFECTOR Therapeutics0.9987 of 5 stars$0.00flat$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010Gap DownONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040Gap Down Related Companies and Tools Related Companies SCPS Alternatives NAVB Alternatives CMRA Alternatives GNCAQ Alternatives GNCA Alternatives ARDS Alternatives STAB Alternatives AMPE Alternatives EFTR Alternatives ONCSQ Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EVLO) was last updated on 1/8/2025 by MarketBeat.com Staff From Our Partners#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredDonald Trump to Repeal Executive Order #14110?Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
